Back
Balchem Corp. 10K Form
Buy
56
BCPC
Balchem Corp.
Last Price:
$170.48
Seasonality Move:
7.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-03 | 10Q | BCPC/Balchem Corp. Quarterly |
| 2024-02-16 | 10K | BCPC/Balchem Corp. Annual |
| 2023-10-27 | 10Q | BCPC/Balchem Corp. Quarterly |
| 2023-07-28 | 10Q | BCPC/Balchem Corp. Quarterly |
| 2023-04-28 | 10Q | BCPC/Balchem Corp. Quarterly |
| 2023-02-24 | 10K | BCPC/Balchem Corp. Annual |
Receive BCPC News And Ratings
See the #1 stock for the next 7 days that we like better than BCPC
BCPC Financial Statistics
Sales & Book Value
| Annual Sales: | $1B |
|---|---|
| Cash Flow: | $51.1M |
| Price / Cash Flow: | 31.84 |
| Annual Sales: | $39.22 |
| Price / Book: | 4.31 |
Profitability
| EPS (TTM): | 4.75030 |
|---|---|
| Net Income (TTM): | $154.8M |
| Gross Margin: | $370.6M |
| Return on Equity: | 12.52% |
| Return on Assets: | 9.36% |
Balchem Corp. Earnings Forecast
Key Balchem Corp. Financial Ratios
-
The Gross Profit Margin over the past 42 years for BCPC is 35.74%.
-
The Selling, General & Administrative Expenses for BCPC have been equal to 13.77% of Gross Profit Margin.
-
The Research & Development expenses have been 1.78% of Revenue.
-
The Interest Expense is 6.60% of Operating Income.
-
The Net Earning history of BCPC is 14.93% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 27 years.
Balchem Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | BCPC |
| CUSIP: | 057665 |
| Website: | balchem.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 2.07 |
| Quick Ratio: | 1.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 35.59 |
|---|---|
| Forward P/E Ratio: | 27.83 |
BCPC Technical Analysis vs Fundamental Analysis
Buy
56
Balchem Corp. (BCPC)
is a Buy
Is Balchem Corp. a Buy or a Sell?
-
Balchem Corp. stock is rated a BuyThe current Balchem Corp. [BCPC] share price is $170.42. The Score for BCPC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.